Dr David Welsh

  • Research Fellow (Institute of Cardiovascular and Medical Sciences)

telephone: 01412112187
email: David.Welsh@glasgow.ac.uk

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Mechanisms underlying the development of pulmonary arterial hypertension
    Medical Research Council
    2013 - 2018
     
  • Acute Pulmonary Haemodynamic Effects of Apelin in Pulmonary Hypertension
    British Heart Foundation
    2012 - 2014
     
  • Role of the fibroblast in pulmonary vascular remodelling: paracrine signalling and molecular mechanisms
    Wellcome Trust
    2009 - 2012
     

Publications

List by: Type | Date

Jump to: 2014 | 2012 | 2009 | 2008 | 2007
Number of items: 6.

2014

Shao, D. et al. (2014) Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension. Biochemical and Biophysical Research Communications, 451(1), pp. 8-14. (doi:10.1016/j.bbrc.2014.06.111) (PMID:25003325)

2012

Carlin , C., Celnik, D., Pak, O., Wadsworth, R., Peacock, A., and Welsh, D. (2012) Low-dose fluvastatin reverses the hypoxic pulmonary adventitial fibroblast phenotype in experimental pulmonary hypertension. American Journal of Respiratory Cell and Molecular Biology, 47(2), pp. 140-148. (doi:10.1165/rcmb.2011-0411OC)

2009

Weerackody, R. P., Welsh, D. J., Wadsworth, R. M., and Peacock, A. J. (2009) Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction. AJP: Heart and Circulatory Physiology, 296(5), H1312-H1320. (doi:10.1152/ajpheart.00977.2008)

2008

Dempsie, Y. et al. (2008) Converging Evidence in Support of the Serotonin Hypothesis of Dexfenfluramine-Induced Pulmonary Hypertension With Novel Transgenic Mice. Circulation, 117(22), pp. 2928-2937. (doi:10.1161/CIRCULATIONAHA.108.767558)

Syyed, R., Reeves, J. T., Welsh, D., Raeside, D., Johnson, M. K., and Peacock, A. J. (2008) The Relationship Between the Components of Pulmonary Artery Pressure Remains Constant Under All Conditions in Both Health and Disease. Chest, 133(3), pp. 633-639. (doi:10.1378/chest.07-1367)

2007

Carlin, C., Peacock, A., and Welsh, D. (2007) Fluvastatin inhibits hypoxic proliferation and p38 MAPK activity in pulmonary artery fibroblasts. American Journal of Respiratory Cell and Molecular Biology, 37(4), pp. 447-456. (doi:10.1165/rcmb.2007-0012OC)

This list was generated on Sun Apr 26 20:16:54 2015 BST.
Jump to: Articles
Number of items: 6.

Articles

Shao, D. et al. (2014) Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension. Biochemical and Biophysical Research Communications, 451(1), pp. 8-14. (doi:10.1016/j.bbrc.2014.06.111) (PMID:25003325)

Carlin , C., Celnik, D., Pak, O., Wadsworth, R., Peacock, A., and Welsh, D. (2012) Low-dose fluvastatin reverses the hypoxic pulmonary adventitial fibroblast phenotype in experimental pulmonary hypertension. American Journal of Respiratory Cell and Molecular Biology, 47(2), pp. 140-148. (doi:10.1165/rcmb.2011-0411OC)

Weerackody, R. P., Welsh, D. J., Wadsworth, R. M., and Peacock, A. J. (2009) Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction. AJP: Heart and Circulatory Physiology, 296(5), H1312-H1320. (doi:10.1152/ajpheart.00977.2008)

Dempsie, Y. et al. (2008) Converging Evidence in Support of the Serotonin Hypothesis of Dexfenfluramine-Induced Pulmonary Hypertension With Novel Transgenic Mice. Circulation, 117(22), pp. 2928-2937. (doi:10.1161/CIRCULATIONAHA.108.767558)

Syyed, R., Reeves, J. T., Welsh, D., Raeside, D., Johnson, M. K., and Peacock, A. J. (2008) The Relationship Between the Components of Pulmonary Artery Pressure Remains Constant Under All Conditions in Both Health and Disease. Chest, 133(3), pp. 633-639. (doi:10.1378/chest.07-1367)

Carlin, C., Peacock, A., and Welsh, D. (2007) Fluvastatin inhibits hypoxic proliferation and p38 MAPK activity in pulmonary artery fibroblasts. American Journal of Respiratory Cell and Molecular Biology, 37(4), pp. 447-456. (doi:10.1165/rcmb.2007-0012OC)

This list was generated on Sun Apr 26 20:16:54 2015 BST.